physio-control lifepak 1000 defibrillators 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Physio-Control 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2017-01-16
  • 사례 출판 날짜
    2017-01-16
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: physio-control lifepak 1000 defibrillators the united states food and drug administration (fda) has posted a medical device safety alert concerning lifepak 1000 defibrillator, manufactured by physio-control. the manufacturer announced that they are launching a voluntary field action for the lifepak 1000 defibrillator due to reported instances where the device has shut down unexpectedly during patient treatment. the manufacturer has received 34 reports where customers have attempted to use their lifepak 1000 defibrillator and the device has shut down unexpectedly due to an intermittent connection between the battery and device electrical contacts. a defibrillator in this scenario may not be able to deliver therapy during a resuscitation attempt, which may expose patients to the risk of serious harm or death. the manufacturer is aware of 8 adverse events related to this issue. the manufacturer has determined that this intermittent connection is a result of wear and subsequent oxidation formation between the battery and device electrical contacts. this condition can occur over time in lifepak 1000 devices that are exposed to vibration and have a battery installed for long periods of time. this issue can potentially affect any lifepak 1000 device, however customers with non-rechargeable batteries who do not routinely remove the battery for inspection, as indicated in the lifepak 1000 defibrillator operating instructions, are more susceptible to this issue. the manufacturer is contacting customers and advising them to immediately remove and reinstall the battery from their device(s). customers are also being advised to implement a weekly schedule of battery removal and reinstallation for all lifepak 1000 devices. the removal and reinstallation of the battery will clean the contacts of oxidation and will reduce the likelihood of this issue from occurring. the manufacturer will be initiating a hardware device correction for all affected lifepak 1000 devices and they will contact customers to schedule device corrections once the hardware correction is ready for implementation. for details, please refer to the fda websites: http://www.Fda.Gov/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/ucm537116.Htm http://www.Fda.Gov/safety/recalls/ucm537114.Htm if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 16 january 2017.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 의료기기 분류등급
  • 제품 설명
    Medical Device Safety Alert: Physio-Control LIFEPAK 1000 Defibrillators
  • Manufacturer

Manufacturer

  • 제조사 모회사 (2017)
  • Source
    DH